Nexstim Plc (FRA:5NX)

Market Cap	69.77M -32.4%
Revenue (ttm)	11.69M +16.2%
Net Income	50.10K
EPS	0.01
Shares Out	n/a
PE Ratio	1,635.83
Forward PE	53.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30
Open	8.40
Previous Close	8.67
Day's Range	8.40 - 8.40
52-Week Range	7.94 - 14.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 25, 2027

About Nexstim

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company offers non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS), including Navigated Brain Stimulation (NBS) system 6 for presurgical mapping of the speech and motor cortices of the brain, for the treatment of major depression and chronic unilateral neuropathic pain, and post-operative rehabilitation of motor defici...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 44
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5NX

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error